Quantabio Launches Ultra-Sensitive sparQ mRNA-Seq Kit

BEVERLY, Mass. – June  8th, 2023 – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and life science research applications, today announced a new ultra-sensitive sparQ mRNA-Seq Kit, which enables preparation of stranded mRNA-seq libraries for Illumina® NGS platforms. The streamlined workflow captures polyadenylated or poly(A) transcripts, helps reduce hands-on time and allows sample to sequencing in a single day.

The proprietary enzymes included in the sparQ mRNA-Seq Kit allow scientists to prepare high-quality, reliable libraries from as little as 5 ng and up to 1 µg of total RNA input. The libraries consistently demonstrate elevated strand specificity across input levels for downstream gene expression analysis and reproducible transcript profiling across biological replicates for better quantification. The efficient isolation of mRNA enables researchers to detect most coding genes.

“Quantabio continues to add to our portfolio of innovative NGS solutions,” said Heather Meehan, PhD, General Manager of Quantabio. “The speed and sample input versatility of the new sparQ mRNA-Seq Kit makes it ideal for a broad range of gene expression analysis applications, including agrigenomics and drug discovery. Customers can now generate high-quality mRNA libraries with greater consistency and less bias, all for up to 30% less overall cost compared to alternative solutions.”

The sparQ mRNA-Seq Kit is available in 24 and 96-reaction configurations. For more information, please visit: https://www.quantabio.com/product/sparq-mrna-seq-kit/ 

About Quantabio

Quantabio is a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational and life science research. For the past 20 years, the Quantabio team has been developing pioneering amplification technologies to deliver cutting-edge products to researchers focused on critical PCR, qPCR and Next-Generation Sequencing (NGS) based applications. Based in Beverly, Mass., Quantabio offers a growing portfolio of products through its international sales operations, as well as a global network of distributors and commercial service providers. For more information, please visit www.quantabio.com.

 

Quantabio products are intended for molecular biology applications. This product is not intended for the diagnosis, prevention, or treatment of a disease.